Chapter 69: Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

So picture this, it's the late 1990s and researchers are testing this brand new cardiac medication.

Right, they were hoping it would completely revolutionize how we treat angina.

Exactly, but it turned out to be like a total dud for the heart, just practically useless.

Yeah, the cardiovascular benefits were pretty minimal.

But then researchers noticed something highly unusual during these clinical trials.

The male patients suddenly refused to give their leftover pills back.

Which is always a red flag in a trial.

Seriously, they were reporting a very specific side effect that would, you know, go on to entirely change medical history.

It really did.

Welcome to this deep dive into chapter 69 of Len's Pharmacology for Nursing Care, the 12th edition.

If you're a nursing student prepping to conquer this pretty dense material, you are in exactly the right place.

We've got a lot of ground to cover today.

We really do.

We are unpacking the drugs used for erectile dysfunction, benign prosthetic hyperplasia,

and premature ejaculation.

But before we actually dive into the pharmacology, the textbook includes this really vital contextual note on inclusivity.

And you definitely need this for your actual nursing practice.

Right, it's super important to lay that groundwork.

Yeah.

So throughout chapter 69, the text uses the terms male and men to refer to cisgender men.

However, these conditions and the drugs we're going to explore, they apply to any patient with a Y chromosome who identifies as female, but has a penis or a prostate.

Okay, that makes sense.

The medical community is just, well, currently lacking robust clinical studies on how these specific drugs interact with active gender reforming therapy protocols.

Got it.

So keeping that clinical reality in mind, let's go back to that failed cardiac drug, which of course became sildenafil or Viagra.

A blockbuster.

Right.

To understand how it works, we have to recognize that these medications don't just magically create a physiological process out of thin air.

They just prevent a natural process from turning itself off.

Exactly.

So what is actually happening at the cellular level during a normal erection?

What's the baseline?

Well, the cascade is this precise chain of events, and it's outlined really well in figure 69 .1 of your text.

It always begins with sexual arousal.

Okay.

That arousal triggers parasympathetic nerve traffic down to the penis, and that specific nerve traffic causes local release of nitric oxide.

And nitric oxide is basically the body's great vasodilator.

It is.

It acts on an enzyme called guanilil cyclis, turning it on.

And the entire job of guanilil cyclis is to just manufacture a messenger molecule called cyclic guanosine monophosphate,

or CGMP for short.

Right, CGMP.

Through a series of steps, that newly minted CGMP promotes the relaxation of both arterial and trabecular smooth muscle within the penis.

So the arterial dilation basically widens the pipes, right?

Increasing the local blood flow and blood pressure.

Exactly.

Blood rushes into the sinusoidal spaces in the corpus cavernosum, making them balloon up.

And because those spaces are engorging so rapidly, they physically press against the veins that drain the penis, basically pinching them shut.

Ah, I see.

So the blood flows in really rapidly, but then it gets trapped.

Right.

That engorgement produces the erection.

But the body naturally produces an enzyme to reverse this, right?

Otherwise it would just last forever.

Yeah.

The natural off switch is an enzyme called phosphodiesterase type 5, or PDE5.

Its whole function is to sweep in and remove the CGMP.

So it cleans up the messenger.

Exactly.

Without CGMP, the smooth muscle stops relaxing, the veins open back up, and the erection subsides.

Okay, so I like to think of it like this.

Essentially, CGMP is the bouncer at a really exclusive nightclub.

I love this analogy.

Right.

When the bouncer is at the door, he's letting all the blood flow into the club, the party is going strong.

But the PDE5 enzyme, that's the police showing up to shut the party down, they get rid of the bouncer and everyone has to leave.

So sildenafil, our prototype PDE5 inhibitor, basically distracts the cops.

That is exactly what it does.

It selectively inhibits the PDE5 enzyme.

Yeah.

By keeping the police busy, sildenafil preserves the levels of CGMP that are already in the penis.

Oh, so the bouncer stays at the door.

The bouncer stays at the door, the smooth muscle stays relaxed, and the erection becomes harder and longer lasting.

And this mechanism is why the drug failed as a widespread cardiac medicine, but cured erectile dysfunction.

Right.

The cardiovascular benefits were just minimal compared to the really intense localized effect in the corpus cavernosum.

Though nursing students, you should definitely note for your exams that sildenafil actually is approved for pulmonary arterial hypertension.

It's just sold under the brand name Rivasio.

Good catch.

Now patients ask about this mechanism all the time, often with a lot of misconceptions.

Like if a patient takes a PDE5 inhibitor, but they are not sexually stimulated in any way, does the bouncer just start letting people into the club randomly?

That's a huge misconception.

No, nothing happens without arousal.

Sildenafil only enhances the normal physiological response to sexual stimuli.

So no arousal means no effect.

Right.

Looking back at the cascade, arousal causes the initial release of nitric oxide to manufacture the CGMP.

Without arousal, there is literally no CGMP being made in the first place for the drug to protect.

So the drug just protects what the body makes.

Exactly.

Okay, now as nurses, our primary focus is always safety.

We know how these PDE5 inhibitors keep the party going, but we really need to understand the severe adverse effects and the major red flags when the pharmacology gets out of hand.

Right.

If you're at the bedside and you see both the nitrate like nitroglycerin for angina and sildenafil on a patient's chart,

why is that an immediate hard stop?

It is an absolute contraindication because of the compounding effect on CGMP.

Nitrates actively increase the formation of CGMP to dilate blood vessels and relieve chest pain.

But then sildenafil simultaneously slows the breakdown of CGMP.

Taking both leads to this massive unchecked accumulation of CGMP in the systemic blood vessels.

Oh man, it is like doubling down on the brakes of a car.

That's a great way to put it.

Because both of these drugs are screaming at the blood vessels to relax.

Taking them together completely removes all vascular resistance and the patient's blood pressure just crashes into profound life -threatening hypotension.

It's incredibly dangerous.

Because the hypotension is so severe,

you have to enforce a strict waiting period.

How long?

There must be at least 24 hours between a dose of sildenafil and administering any nitrate.

And if the patient is taking didalafil, which is another drug in this class, the mandatory wait is actually 48 hours.

Wow, 48 hours.

Why is it longer?

It has a much longer half -life.

You also have to exercise extreme caution with alpha blockers, which we will look at later for prostate issues.

Because combining those with a PDE5 inhibitor can also strip away vascular resistance and cause symptomatic postural hypotension.

Okay, we'll bookmark that.

But trapping all that localized blood in the corpus cavernosum can't be risk -free either.

What if the off switch gets permanently disabled by the drug?

That leads to priapism, which is an erection lasting more than four hours.

And that is a serious medical emergency.

More than four hours?

Lift untreated, the trapped blood becomes stagnant and completely deprived of oxygen.

Yikes.

So what's the treatment?

The treatment requires a provider to aspirate the stagnant blood out of the corpus cavernosum with a needle.

Wait, literally aspirate it with a needle?

Yes.

And then they have to irrigate the area with a vasoconstrictor, forcing the blood vessels to clamp down.

If priapism persists beyond 24 hours, the patient will likely suffer permanent tissue damage.

Oh, wow.

Yeah, they may completely lose the ability to have intercourse ever again.

Okay, so a 24 -hour window before permanent damage.

That is a vital patient teaching point.

You have to counsel your patients not to let embarrassment delay a trip to the emergency room.

Absolutely.

The text also mentions a few very rare but serious sensory effects we should track, right?

Yeah, there are documented, albeit very rare, reports of non -arteritic ischemic optic neuropathy or NAIA ion.

What does that do?

This condition causes irreversible blurring or even vision loss because blood flow to the optic nerve is physically blocked.

We also see rare cases of sudden hearing loss, which might present with dizziness or tinnitus.

So what's the protocol if that happens?

If a patient experiences sudden vision or hearing loss, they must stop taking the PDE5 inhibitor immediately and seek urgent medical evaluation.

Okay, noted.

So if sildenafil is the standard prototype, why do we have three other versions listed in tables 69 .2 and 3?

Like, do Tadalafil, Avinafil, and Vardenafil offer distinct clinical benefits, or are they just copycats?

They're not just copycats.

They offer different pharmacokinetics to fit different patient lifestyles.

Oh, okay.

For example, Tadalafil, sold as Cialis, has an incredibly long half -life.

Its effects can last up to 36 hours.

36 hours.

Right.

And because it stays in the system so long, it is the only one in the entire class approved for scheduled daily dosing, rather than just PRN or as -needed use.

That makes sense.

What about Avinafil?

Avinafil sold as Stendra.

Its main clinical benefit is speed.

It has the fastest onset, working in just 15 minutes.

Just 15 minutes.

And what about Vardenafil?

Vardenafil is highly testable on nursing exams because of a really unique adverse effect.

It prolongs the QT interval on an electrocardiogram.

Oh, so a cardiac issue.

Yes.

This means it delays intracular repolarization in the heart, increasing the risk for potentially fatal dysrhythmias.

Yeah.

Therefore, you must avoid giving Vardenafil to patients who are already taking class 1 or class 3 antidisrhythmic drugs.

Because that would just compound the QT prolongation.

Exactly.

It's too dangerous.

Now, what about food interactions?

Because if a patient takes one of these shorter acting PRN doses right after, like a big steak dinner, does that change the absorption?

Oh, significantly.

High -fat meals significantly delay the absorption of sildenafil, avanafil, and Vardenafil.

Why is that?

High lipid content in the gastrointestinal tract just slows down gastric emptying.

The pill just sits in the stomach longer before reaching the small intestine where it can actually be absorbed.

That delays the onset of action considerably.

Okay.

So we've seen how dangerous it is to artificially manipulate blood flow when the cardiovascular system is already compromised.

For those high -risk patients who simply can't safely take an oral PDE5 inhibitor, we have to bypass the systemic circulation entirely, right?

And go strictly local with second -line ED meds.

Yes, exactly.

The primary localized option is alprostidyl.

The active ingredient here is chemically identical to prostaglandin E1, which is a potent, direct vasodilator.

So it works totally differently.

Completely differently.

By introducing it directly to the local tissue, it relaxes the smooth muscle and causes a rapid inflow of arterial blood.

It completely bypasses that nitric oxide and CGMP pathway we discussed earlier.

But getting the drug directly to the local tissue, that requires some intense administration techniques, doesn't it?

It does.

The patient really has two options.

The first is urethral pellets under the brand name Muse.

Pellets.

Yeah, the patient uses a small plastic applicator to insert a tiny pellet, 1 .5 inches directly into the urethra, where the drug is absorbed through the urethra mucosa.

Ouch.

And the second option?

The second option is injecting the drug directly into the corpus cavernosum using brands like Cavergect or Edex.

Wow.

Okay, but I guess the adverse effects must be mostly localized to the site of administration, right?

Systemic hypotension wouldn't be as much of a risk here.

You're right.

Systemic effects are very rare.

The primary complaints are local.

About 32 % of users report a dull ache in the penis.

The urethral pellets frequently cause urethral burning.

That makes sense.

And with the direct injections, there is a cumulative risk of developing painless fibrotic nodules in the penile tissue over time.

That's just due to the repeated needle trauma and the local drug effects.

The text also mentions a compounded mixture of paparin and fentolamine.

What's the deal with that?

So that combination mixes a direct vasodilator with an alpha -edrenergic blocker.

But it is crucial to know for your practice that this mixture is not FDA approved for erectile dysfunction.

Oh, it's not approved.

No, it carries a significant risk of priapism and those same fibrotic nodules.

Furthermore, because it has to be mixed by compounding pharmacies, providers often have lingering concerns about sterility, stability, and overall quality control.

Okay, so that's a lot of red flags.

So far, we've focused on the mechanical blood flow of an erection.

Let's transition to a condition defined entirely by timing and neurology, which is premature ejaculation or PE.

Right.

The clinical definition the textbook provides is much stricter than what I think the general public thinks of.

It is very specific.

The International Society of Sexual Medicine defines PE using three strict criteria.

First,

ejaculation must occur within one minute of penetration for lifelong PE or within two to three minutes for acquired PE.

Okay, so time is the first factor.

Second, the patient experiences an inability to delay ejaculation during almost all penetrations.

And third, the condition must cause significant psychological distress.

Right, the distress piece is key.

And the pathophysiology behind this timing issue is driven by neurotransmitter dysregulation, isn't it?

Yes, the current neuropharmacological understanding is that serotonin acts to delay ejaculation, whereas dopamine and oxytocin stimulate it.

Interesting.

So a patient experiencing PE may have an altered sensitivity to serotonin or simply lower levels of it active in the synaptic cleft during sexual activity.

This brings us to a brilliant example of how pharmacology evolves.

Because earlier in the textbook, we learned that SSRI's selective serotonin reuptake inhibitors like fluoxetine, they cause sexual dysfunction as an adverse effect in up to 70 % of people taking them for depression.

Right.

But for PE, we are harnessing that exact adverse effect and using it as our primary therapeutic goal.

That's so cool.

It's great pivot.

By prescribing an SSRI off -label, we intentionally block the reuptake of serotonin.

This leaves more serotonin lingering in the synapse, which essentially strengthens that delaying signal to the ejaculation reflex.

And peroxetine seems to be the preferred choice here.

Peroxetine appears to be the most effective SSRI for this specific use.

But you just have to teach the patient that, much like treating depression, it takes two to three weeks of daily dosing for the neurotransmitter levels to adjust and achieve the maximal response.

It's not a take it when you need it kind of pill.

Right.

Now, if a patient doesn't want to take a daily systemic antidepressant to treat a localized issue, the text mentions topical anesthetics like Lidocaine or pre -locaine creams.

These decrease the physical sensitivity of the gland's penis, but this comes with a massive nursing implication, like huge.

Absolutely massive.

The patient must use a condom if they apply a topical anesthetic.

Because if they don't.

If they apply a numbing cream and proceed to have unprotected intercourse, they will transfer that anesthetic directly to their partner's vaginal or anal mucosa.

Which is obviously bad.

Right.

This results in unintended numbness and delayed orgasm for the partner,

completely undermining the entire goal of the therapy.

Yeah, that is a crucial teaching point right there.

All right.

Let's shift our focus from the vascular tissue of the penis to the glandular and smooth muscle tissue of the prostate,

specifically looking at benign prostatic hyperplasia.

BPH is incredibly common in older patients.

Yeah, and the prostate is a heart -shaped gland that wraps entirely around the urethra.

When it enlarges, it basically squeezes the urethra like a clamp, causing urinary hesitancy, urgency, frequency, and that terrible feeling that the bladder is never completely empty.

Right.

And to treat BPH effectively, you have to distinguish between the two different types of tissue causing that obstruction.

Okay, break that down for us.

The first is mechanical obstruction.

This is caused by the physical overgrowth of epithelial cells, which is the glandular tissue.

It forms this bulky mass that physically presses down on the urethra.

And the second type?

The second is dynamic obstruction.

This is caused by the overgrowth of smooth muscle cells within the prostate capsule and the bladder neck.

The muscle gets too tight and pinches the urethra shut.

To help students lock this in, think of a slowly draining sink.

The mechanical block is all the physical gunk clogging the pipe.

The dynamic block is if the pipe itself is somehow like squeezing shit.

That's a perfect visual.

So we have two distinct drug classes to attack these two different problems.

Let's start with class one, the five alpha reductase inhibitors, which includes finasteride and detasteride.

Right.

These drugs are designed to clear the mechanical obstruction.

They block the enzyme five alpha reductase, which is responsible for converting testosterone into dihydrotestosterone, or DHT.

And DHT is the bad guy here.

Well, DHT is the active signaling molecule that tells the prostate epithelial cells to grow and multiply.

By blocking DHT production,

finasteride removes that growth signal and the bulky epithelial tissue slowly shrinks.

Because they physically shrink the size of the gland, these drugs are best suited for patients with very large prostates, right?

Yes.

But a patient isn't going to see instant relief with this, are they?

No.

Reversing tissue growth takes a lot of time.

It often takes six to 12 months of daily adherence before a patient notices a significant improvement in their urinary flow.

Wow.

Okay.

There is also a massive nursing safety alert for this class.

We need neon flashing lights for this one, because these are classified as hazardous drugs.

Extremely hazardous.

They are freely teratogenic to the XY fetus.

A pregnant nurse or a patient's pregnant partner must absolutely not handle crushed or broken finasteride or detasteride tablets.

Because of skin absorption.

Yes.

The active drug can be absorbed directly through the skin and disrupt the development of male genitalia in a growing fetus.

Geez.

Furthermore, patients taking these drugs are strictly barred from donating blood, just in case that blood is later transfused into a pregnant patient.

Exactly.

There's also a major monitoring parameter regarding cancer screening, right?

Finasteride and detesteride artificially lower prostate -specific antigen, or PSA levels, by 30 to 50 percent.

And this is a critical concept for ongoing care.

If a patient's baseline PSA, before starting the drug, was a 4,

finasteride will artificially drop it down to a 2.

Okay.

Bath time.

Right.

So if a year later, their lab results show their PSA has crept back up to a 4, a provider who isn't paying close attention might think a 4 is perfectly normal.

Because 4 was the baseline.

Exactly.

But because the drug cuts the value in half, that lab value of 4 actually represents a true PSA of 8.

Oh, wow.

That's a huge difference.

It is.

You must draw a baseline PSA before initiating therapy and account for that artificial drop in all future labs to avoid missing a hidden prostate cancer diagnosis.

That is such an important catch.

So finasteride dissolves the bulky gunk over months.

How do we address the tight, smooth muscle to widen the pipe right now?

That brings us to class 2,

the alpha -1 adrenergic antagonists.

These are the alpha blockers, and they target the dynamic obstruction.

They block alpha -1 receptors, which signals the smooth muscle in the bladder neck, prostate capsule, and proscatic urethra to relax.

Oh, so they open things right up.

Yeah, this relieves the dynamic pinch on the urethra.

And unlike finasteride, alpha blockers work rapidly, offering noticeable symptom relief in just days to weeks.

But there is a major distinction within this class regarding receptor specificity.

We have selective alpha blockers, like cilidocin and tamcylosin, which is better known as Flomax.

The selective agents only target the specific alpha -1A receptors that are primarily located in the prostate.

Because their action is so localized, they have very little effect on systemic blood pressure.

That's a nice benefit.

What about adverse effects?

Their most common adverse effect is abnormal ejaculation,

specifically retrograde ejaculation, where the relaxed bladder neck allows semen to flow backward into the bladder instead of out the urethra.

Okay, interesting.

Now contrast that with the non -selective alpha blockers, like alfizosin, doxizosin, and terezosin.

The non -selective agents block the alpha -1 receptors in the prostate, but they also block the alpha -1B receptors found in blood vessels all over the body.

And by blocking those vascular receptors, you induce widespread vasodilation.

Exactly.

That totally explains the major adverse effects, right?

Hypotension, fainting, and dizziness.

And the vasodilation also explains why they cause severe nasal congestion.

The blood vessels in the nasal mucosa dilate and swell up.

In fact, doxizosin and terezosin were originally developed as blood pressure medications.

Wait, really?

Yes.

So if you have a patient with BPH who also has systemic hypertension, a non -selective agent can efficiently treat both conditions with just one pill.

Oh, that's convenient.

But if the patient has normal blood pressure, a non -selective agent could cause them to completely bottom out, making a highly -targeted selective agent like Tamsulosin the much safer choice.

Got it.

There's also a bizarre but serious clinical note regarding eye surgery.

Yeah, alpha blockers can cause a surgical complication known as floppy iris syndrome during cataract removal, leading to severe vision issues postoperatively.

So what do you do?

Any patient anticipating cataract surgery should postpone starting an alpha blocker.

If they're already on one, they must aggressively inform their ophthalmologist before the procedure so the surgeon can alter their technique.

Good to know.

Now, since most BPH involves both a bulky prostate pressing down and tight, smooth muscle pinching in, it makes sense to use a two -pronged approach, right?

It absolutely does.

Clinical trials clearly prove that combining an alpha blocker for that fast symptom relief with a 5 -alpha retase inhibitor to shrink the prostate long -term is vastly superior to using either drug alone.

Do they have to take two pills?

You can actually administer them together in a single capsule, like Jalen, which is a combination of Tamsulosin and

called Entad -Fe.

This leverages the PDE5 inhibitor's smooth, muscle -relaxing properties for BPH symptoms, though it's currently only approved for up to 26 weeks of use.

Okay, and if pills aren't enough, but the patient isn't ready for surgery, we have a few other pharmacological tools.

If they experience severe overactive bladder symptoms, we can add anticholinergics to relax the bladder muscle.

Right.

The text also notes that botulinum toxin, or Botox, can be injected directly into the prostate.

It blocks the localized release of acetylcholine, inducing muscle relaxation that can relieve symptoms for up to a year.

You will also encounter patients trying to treat their BPH with complementary and alternative medicine.

Oh yeah, salt palmetto is everywhere in the supplement aisle.

People buy it because it's marketed as a natural way to block that same 5 -alpha -reductase enzyme without a prescription.

Right.

But the textbook highlights the clinical reality here.

A massive Cochrane review analyzed 32 randomized controlled trials involving over 5 ,600 men.

That's a huge sample size.

It is.

And the data showed conclusively that salt palmetto is no better than a placebo at relieving BPH symptoms, even when taken at high doses.

Based on this overwhelming lack of evidence, the American Urological Association explicitly recommends against using it.

Well there you go.

So when you step onto the floor as a nurse, how do you synthesize all of this?

You turn to the summary of major nursing implications at the end of Chapter 69.

That's the best tool in the book.

It really is.

It reminds you to rigorously evaluate cardiovascular risk before administering any PDE -5 inhibitor.

It tells you to track whether your patient is taking Tadalafel daily or sildenafel PRN, and to account for how a high -fat hospital dinner might delay absorption.

Above all, it demands that you monitor fiercely for hypotension, especially when alpha blockers and PDE -5 inhibitors end up on the same medication administration record.

Mastering this chapter requires moving past rote memorization.

It is all about understanding the underlying mechanism of action.

You're either preserving CDMP to maintain smooth muscle relaxation and erectile dysfunction,

increasing synaptic serotonin to delay ejaculation in PE, or deliberately targeting epithelial versus smooth muscle growth in BPH.

Pharmacology is simply applied physiology.

That's a great way to summarize it.

I want to leave you with a final thought as you prepare for your exams and your clinicals.

Consider how the frustrating side effects of one medical era become the blockbuster life -changing therapies of the next.

It's so true.

I mean, sildenafel caused unexpected erections and failed cardiac trials.

SSRIs caused frustratingly delayed ejaculation and depression treatments.

As you move forward in your nursing career, paying close attention to your patients, what other adverse effects might you witness on the floor today that could become the breakthrough therapies of tomorrow?

It definitely forces you to look at a medication error report or an unexpected symptom complaint in a completely new light.

It really does keep your eyes open out there.

With that, a warm thank you from the last minute lecture team.